Zobrazeno 1 - 10
of 28
pro vyhledávání: '"I S Denisov"'
Publikováno v:
Терапевтический архив, Vol 89, Iss 5, Pp 10-19 (2017)
Aim. To determine risk factors for severe cardiovascular (CV) events (CVEs) in male patients with crystal-verified gout. Subjects and methods. 251 male patients with crystal-verified gout were prospectively followed up in 2003 to 2013. The mean follo
Externí odkaz:
https://doaj.org/article/16eafdbc9a414ad5967865c1848ad492
Publikováno v:
Терапевтический архив, Vol 87, Iss 5, Pp 10-15 (2015)
Aim. To estimate the time course of changes in the clinical manifestations of gout and their risk factors during a long-term follow-up. Subjects and methods. A total of 160 male patients with gout were examined and followed up for a mean of 6.9±2.0
Externí odkaz:
https://doaj.org/article/2901bba02b04483db778e3b221f0418f
Publikováno v:
Современная ревматология, Vol 0, Iss 4, Pp 61-65 (2012)
Externí odkaz:
https://doaj.org/article/7907aa4d84334fd98bb43bb3439a9afe
Autor:
V G Barskova, Maksim Sergeyevich Eliseyev, I S Denisov, M E Eliseyeva, O A Belikov, G R Fadiyenko, F S Zharskaya, O P Polkovnikova, A N Kalyagin, M V Sklyanova, E A Shvetsova, L A Knyazeva, I M Marusenko, S E Myasoedova, E A Kozhevnikova, M N Petrova, T A Raskina, M V Koroleva, V V Tyrenko, A A Al-Nuvairakh, A G Khanov
Publikováno v:
Научно-практическая ревматология, Vol 50, Iss 6, Pp 15-18 (2012)
Objective: to study the rate of metabolic syndrome (MS) and its components among gout patients in different regions of the Russian Federation. Subjects and methods. This cross-sectional multicenter study enrolled 2277 gout patients, including 1963 (8
Externí odkaz:
https://doaj.org/article/5b09765dc8c343f08abc5b21d167cb2e
Publikováno v:
Современная ревматология, Vol 0, Iss 3, Pp 49-52 (2012)
The paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric aci
Externí odkaz:
https://doaj.org/article/97340c7d62954f4e932753e282338aea
Publikováno v:
Терапевтический архив, Vol 84, Iss 5, Pp 45-50 (2012)
Aim. To assess survival and lethal outcome risk factors in gout patients. Material and methods. The study included 286 gout patients (246 males, 86% and 49 females, 14%) treated for gout in the Research Institute of Rheumatology from 2001 to 2006. Fr
Externí odkaz:
https://doaj.org/article/42b767bdab38445ea42b16d906dde87d
Publikováno v:
Современная ревматология, Vol 0, Iss 1, Pp 44-48 (2012)
The impact of a 4-week course of therapy with Uralyt-U (potassium-sodium hydrocitrate) on uric acid (UA) metabolic parameters was studied in patients with gout and nephrolithiasis. Elevated daily urinary excretion of UA was found to be directly corre
Externí odkaz:
https://doaj.org/article/f572a38597fa4e44a9ebfefd365d8a16
Publikováno v:
Современная ревматология, Vol 0, Iss 4, Pp 44-48 (2011)
Externí odkaz:
https://doaj.org/article/a6340a9dbef54d3794cf8cf5a3547ad3
Publikováno v:
Научно-практическая ревматология, Vol 49, Iss 6, Pp 28-31 (2011)
Externí odkaz:
https://doaj.org/article/fa1c4923f999479a82d90407b40212e3
Autor:
O A Antelava, I S Denisov, E G Sazhina, Rimma Mikhailovna Balabanova, A N Pogodina, E I Shmidt, Yu A Olyunin, E L Nasonov
Publikováno v:
Современная ревматология, Vol 6, Iss 1, Pp 29-31 (2012)
Externí odkaz:
https://doaj.org/article/1517587aa71d4b8c9dd1bf0eb39c5e9f